Pituitary adenylate cyclase-activating polypeptide deficiency enhances oxazolone-induced allergic contact dermatitis in mice

Journal of Molecular Neuroscience

Volumn 42, Issue 3, 2010, Pages 443-449

  Kemény, Ágnes ^a   Reglődi, Dóra ^a   Cseharovszky, Renáta ^a   Hashimoto, Hitoshi ^b,c,d   Baba, Akemichi ^b   Szolcsányi, János ^a   Pintér, Erika ^a   Helyes, Zsuzsanna ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b OSAKA UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Delayed type hypersensitivity reaction; Ear edema; Histopathological alterations; Inflammatory cytokines; Myeloperoxidase activity

Indexed keywords

ALCOHOL; GAMMA INTERFERON; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; OXAZOLONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HISTOLOGY; HOMOGENATE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; OTITIS; PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE DEFIECIENCY; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; SENSITIZATION; SKIN ALLERGY; THERAPY EFFECT; TREATMENT RESPONSE;

MUS;

EID: 78349306805     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-010-9368-3     Document Type: Article

References (36)

1. C Abad RP Gomariz JA Waschek 2006 Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP Curr Top Med Chem 6 151 163 1:CAS:528:DC%2BD28XitVantrg%3D 10.2174/156802606775270288 16454764
2. A Arimura 2007 PACAP: the road to discovery Peptides 28 1617 1619 1:CAS:528:DC%2BD2sXhtVWms7jK 10.1016/j.peptides.2007.06.006 17719697
3. BD Armstrong C Abad S Chhith, et al. 2008 Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide Neuroscience 151 63 73 1:CAS:528:DC%2BD1cXlsFeitg%3D%3D 10.1016/j.neuroscience.2007.09.084 18055122
4. YT Azuma K Hagi N Shintani, et al. 2008 PACAP provides colonic protection against dextran sodium sulfate induced colitis J Cell Physiol 216 111 119 1:CAS:528:DC%2BD1cXnt1eksLc%3D 10.1002/jcp.21381 18205183
5. M Delgado D Ganea 2001 Inhibition of endotoxin-induced macrophage chemokine production by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide in vitro and in vivo J Immunol 167 966 975 1:CAS:528:DC%2BD3MXotFWktL0%3D 11441105
6. W Ding JA Wagner RD Granstein 2007 CGRP, PACAP, and VIP modulate Langerhans cell function by inhibiting NF-kappaB activation J Invest Dermatol 127 2357 2367 1:CAS:528:DC%2BD2sXhtVeisb%2FJ 10.1038/sj.jid.5700858 17495962
7. D Ganea M Delgado 2002 Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) as modulators of both innate and adaptive immunity Crit Rev Oral Biol Med 13 229 237 10.1177/ 154411130201300303 12090463
8. BM Girard SE Malley KM Braas JA Waschek V May MA Vizzard 2008 Exaggerated expression of inflammatory mediators in vasoactive intestinal polypeptide knockout (VIP-/-) mice with cyclophosphamide (CYP)-induced cystitis J Mol Neurosci 36 188 199 1:CAS:528:DC%2BD1cXhsVagtLnP 10.1007/s12031-008-9084-4 18483878
9. RP Gomariz Y Juarranz C Abad A Arranz J Leceta C Martinez 2006 VIP-PACAP system in immunity. New insights for multitarget therapy Ann N Y Acad Sci 1070 51 74 1:CAS:528:DC%2BD28XpvVehsLg%3D 10.1196/annals.1317.031 16888149
10. I Gozes 2008 VIP, from gene to behavior and back: summarizing my 25 years of research J Mol Neurosci 36 115 124 1:CAS:528:DC%2BD1cXhsVagtLrF 10.1007/s12031-008-9105-3 18607776
11. SL Gray N Yamaguchi P Vencova NM Sherwood 2002 Temperature-sensitive phenotype in mice lacking pituitary adenylate cyclase activating polypeptide Endocrinology 143 3946 3954 1:CAS:528:DC%2BD38Xnt1ygtr4%3D 10.1210/en.2002- 220401 12239106
12. H Hashimoto N Shintani K Tanaka, et al. 2001 Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase activating polypeptide (PACAP) Proc Natl Acad Sci USA 98 13355 13360 1:CAS:528:DC%2BD3MXosFygtb8%3D 10.1073/pnas.231094498 11687615
13. H Hashimoto R Hashimoto N Shintani, et al. 2009 Depression-like behavior in the forced swimming test in PACAP-deficient mice: amelioration by the atypical antipsychotic risperidone J Neurochem 110 595 602 1:CAS:528: DC%2BD1MXovV2mtLs%3D 10.1111/j.1471-4159.2009.06168.x 19457081
14. Zs Helyes G Pozsgai R Borzsei, et al. 2007 Inhibitory effect of PACAP-38 on acute neurogenic and non-neurogenic inflammatory processes in the rat Peptides 28 1847 1855 1:CAS:528:DC%2BD2sXhtVWms7fJ 10.1016/j.peptides.2007.07. 001 17698245
15. ER Isaac NM Sherwood 2008 Pituitary adenylate cyclase-activating polypeptide (PACAP) is important for embryo implantation in mice Mol Cell Endocrinol 280 13 19 1:CAS:528:DC%2BD2sXhsVWjtbvM 10.1016/j.mce.2007.09.003 17945412
16. S Kodali I Friedman W Ding K Seiffert JA Wagner RD Granstein 2003 Pituitary adenylate cyclase activating polypeptide inhibits cutaneous immune function Eur J Immunol 33 3070 3079 1:CAS:528:DC%2BD3sXovFKnur0%3D 10.1002/eji.200324085 14579275
17. M Laburthe A Couvineau V Tan 2007 Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology Peptides 28 1631 1639 1:CAS:528:DC%2BD2sXhtVWms7jF 10.1016/j.peptides.2007.04.026 17574305
18. L Lenti A Zimmermann D Kis, et al. 2009 PACAP and VIP differentially preserve neurovascular reactivity after global cerebral ischemia in newborn pigs Brain Res 1283 50 57 1:CAS:528:DC%2BD1MXptVCjs7o%3D 10.1016/j.brainres.2009.06. 021 19538945
19. JM Muller C Debaigt S Goursaud, et al. 2007 Unconventional binding sites and receptors for VIP and related peptides PACAP and PHI/PHM: an update Peptides 28 1655 1666 1:CAS:528:DC%2BD2sXhtVWms7nO 10.1016/j.peptides.2007.04.006 17555844
20. M Nakata D Kohno N Shintani, et al. 2004 PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus Neurosci Lett 370 252 256 1:CAS:528: DC%2BD2cXos1elsr4%3D 10.1016/j.neulet.2004.08.034 15488333
21. J Németh D Reglodi G Pozsgai, et al. 2006 Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice Neuroscience 143 223 230 10.1016/j.neuroscience.2006.07.028 16938409
22. N Nemetz C Abad G Lawson, et al. 2008 Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP Int J Cancer 122 1803 1809 1:CAS:528:DC%2BD1cXksFeit78%3D 10.1002/ijc.23308 18098289
23. P Niewiadomski AC Coute-Monvoisin C Abad D Ngo A Menezes JA Waschek 2008 Mice deficient in both pituitary adenylyl cyclase-activating polypeptide and vasoactive intestinal peptide survive, but display growth retardation and sex-dependent early death J Mol Neurosci 36 200 207 1:CAS:528:DC%2BD1cXhsVagtLrO 10.1007/s12031-008-9085-3 18491042
24. H Ohtaki T Nakamachi K Dohi S Shioda 2008 Role of PACAP in ischemic neural death J Mol Neurosci 36 16 25 1:CAS:528:DC%2BD1cXhsVagtLvJ 10.1007/s12031-008-9077-3 18483879
25. EM Peters ME Ericson J Hosoi, et al. 2006 Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance J Invest Dermatol 126 1937 1947 1:CAS:528:DC%2BD28XotFCju7Y%3D 10.1038/sj.jid.5700429 16912691
26. B Racz G Horvath N Faluhelyi, et al. 2008 Effects of PACAP on the circadian changes of signaling pathways in chicken pinealocytes J Mol Neurosci 36 220 226 1:CAS:528:DC%2BD1cXhsVagtL3I 10.1007/s12031-008-9112-4 18592414
27. M Reichenstein M Rehavi A Pinhasov 2008 Involvement of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors in the mechanism of antidepressant action J Mol Neurosci 36 330 338 1:CAS:528:DC%2BD1cXhsVagtLvN 10.1007/s12031-008-9116-0 18592413
28. D Roosterman T Goerge SW Schneider NW Bunnett M Steinhoff 2006 Neuronal control of skin function: the skin as a neuroimmunoendocrine organ Physiol Rev 86 1309 1379 1:CAS:528:DC%2BD28Xht1SgtL3P 10.1152/physrev.00026.2005 17015491
29. S Shimakura K Kojima T Nakamachi, et al. 2008 Neuronal interaction between melanin-concentrating hormone- and alpha-melanocyte-stimulating hormone-containing neurons in the goldfish hypothalamus Peptides 29 1432 1440 1:CAS:528:DC%2BD1cXptVGlu7c%3D 10.1016/j.peptides.2008.04.009 18513831
30. M Steinhoff GP McGregor A Radleff-Schlimme A Steinhoff H Jarry WE Schmidt 1999 Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type I receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis Regul Pept 80 49 55 1:CAS:528: DyaK1MXitFans7k%3D 10.1016/S0167-0115(99)00010-5 10235634
31. JW Streilein P Alard H Niizeki 1999 Neural influences on induction of contact hypersensitivity Ann N Y Acad Sci 885 196 208 1:CAS:528: DC%2BD3cXhsVOqtA%3D%3D 10.1111/j.1749-6632.1999.tb08677.x 10816653
32. YV Tan C Abad R Lopez, et al. 2009 Targeted gene deletion reveals that pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance in mice and plays a protective role in experimental autoimmune encephalomyelitis Proc Natl Acad Sci USA 106 2012 2017 1:CAS:528: DC%2BD1MXitVKltrw%3D 10.1073/pnas.0812257106 19190179
33. S Tomimoto T Ojika N Shintani, et al. 2008 Markedly reduced white adipose tissue and increased insulin sensitivity in adcyap1-deficient mice J Pharmacol Sci 107 41 48 1:CAS:528:DC%2BD1cXmsVOmt7w%3D 10.1254/jphs.FP0072173 18446003
34. D Vaudry A Falluel-Morel S Bourgault, et al. 2009 Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery Pharmacol Rev 61 283 357 10.1124/pr.109.001370 19805477
35. MC Weston PT Peachell 1998 Regulation of human mast cell and basophil function by cAMP Gen Pharmacol 31 715 719 1:CAS:528:DyaK1cXntVCrs7o%3D 9809467
36. XY Zhang S Hayasaka ZL Chi HS Cui Y Hayasaka 2005 Effect of pituitary adenylate cyclase activating polypeptide (PACAP) on IL-6, IL-8, and MCP-1 expression in human retinal pigment epithelial cell line Curr Eye Res 30 1105 1111 1:CAS:528:DC%2BD2MXhtlWku7%2FL 10.1080/02713680500421444 16354624